Hanyang Yu Selected Research

Fatigue

8/2023	Review on Fatigue of Additive Manufactured Metallic Alloys: Microstructure, Performance, Enhancement, and Assessment Methods.
1/2022	Variability of Accommodative Microfluctuations in Myopic and Emmetropic Juveniles during Sustained near Work.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanyang Yu Research Topics

Disease

5	Neoplasms (Cancer) 03/2024 - 12/2020
2	Fatigue 08/2023 - 01/2022
1	Inflammation (Inflammations) 01/2024
1	Myopia 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Keratoconus 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Breast Neoplasms (Breast Cancer) 08/2021
1	Liver Neoplasms (Liver Cancer) 11/2020
1	Cerebral Hemorrhage 04/2018

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2021
2	Nucleic AcidsIBA 01/2022 - 12/2020
1	Cysteine (L-Cysteine)FDA Link 03/2024
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	CalciumIBA 03/2024
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	AlloysIBA 08/2023
1	snake venom protein C activatorIBA 01/2023
1	tetraethylpyrazine (TEP)IBA 01/2023
1	palbociclibIBA 01/2023
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2023
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2023
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	ClathrinIBA 01/2022
1	Epirubicin (Ellence)FDA LinkGeneric 01/2022
1	Platelet-Derived Growth FactorIBA 08/2021
1	erythrose (threose)IBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	Ribosomal DNA (rDNA)IBA 11/2020
1	PlatinumIBA 11/2020
1	ProcalcitoninIBA 04/2018

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
1	Lasers (Laser) 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Immunotherapy 12/2020